flore.unifi.it/retrieve/handle/2158/1051025/149792/00006454-201509000-00017.pdf

Merck & Co, Inc. Kenilworth, NJ) received United States (US). Food and Drug Administration ..... V oluntary, passive surveillance system operated by the FDA and CDC. Most AEs were not ...... Mikolajczyk RT, Kraut AA, Horn J, et al. Changes in ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4514396

Apr 27, 2015 ... Prior to the current study, all studies of the immunogenicity, safety, ..... Funding for this study was provided by Merck & Co., Inc., Kenilworth, ... Sitas F, Urban M, Stein L, Beral V, Ruff P, Hale M, Patel M, O'Connell D, Yu XQ, Verzijden A, et al. ..... Mikolajczyk RT, Kraut AA, Horn J, Schulze-Rath R, Garbe E.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3618302

Jan 25, 2013 ... Kraut et al., 2010 [34] ... van den Broek et al., 2010 [39] ..... This study was funded by Merck & Co., Inc. Harshila Patel PhD and Monika Wagner ..... Bouee S, Lafuma A, Benard S, Remy V. [Anogenital warts incidence, medical ...

onlinelibrary.wiley.com/doi/full/10.15252/emmm.201404596

Nov 24, 2014 ... Norbert Kraut .... For EGFR TKIs, all of the above mechanisms of acquired resistance have ... for proliferating versus non‐proliferating cells (Steegmaier et al, 2007; .... A single biomedical company rarely has adequate resources or the ... of AstraZeneca's MEK inhibitor and Merck's AKT inhibitor in multiple ...

www.herontx.com/sites/default/files/pdfs/posters-presentations/fon-2018-0311.pdf

Jun 6, 2018 ... 2Clinical Operations, Heron Therapeutics, Inc., 4242 Campus Point ... No HTX- 019 recipients had infusion-site adverse events, versus 15 ... TEAEs occurred; all TEAEs resolved. ... Ottoboni, Lauw, Keller et al. ...... Kraut L, Fauser AA. ... Coors EA, Seybold H, Merk HF, Mahler V. Polysorbate 80 in medical ...

www.nccn.org/professionals/meetings/22ndannual/pdf/AC2017_ExhibitGuide.pdf

Mar 23, 2017 ... Jazz Pharmaceuticals, Inc.; Pharmacyclics LLC, an AbbVie Company; and Teva .... Seating is open for all conference attendees in the Exhibitor ...

www.cell.com/cell-reports/abstract/S2211-1247(16)31647-3

Gronemeyer H. Gustafsson J.A.; Laudet V. ... Huh J.R.; Leung M.W.; Huang P. Ryan D.A.; Krout M.R.; Malapaka R.R.; Chow J. Manel N. Ciofani M. Kim S.V.; et al.

www.bu.edu/bulawreview/files/2018/01/PARASIDIS.pdf

27 Robert T. Chen et al., The Vaccine Adverse Event Reporting System (VAERS), 12 ..... A recent case filed against Merck, alleging that the company ..... 1930); Krout v. ..... Asker v. Wyeth Pharmaceuticals, Inc.,132 a California appellate court.

elifesciences.org/articles/26980

Jul 10, 2017 ... Using a genetic screening approach, van der Lelij, Lieb et al. searched for .... Co- depletion of p53 and STAG1 indicated that the dependency of ..... time points using a Guava easycyte flow cytometer (Merck Millipore, ..... mRNA expression is not elevated in STAG2 mutated versus STAG2 .... Norbert Kraut.